Why is the Baclofen-based painkiller Baclofen prescribed?
Baclofen is a muscle relaxant that relieves muscle spasms and stiffness caused by various conditions such as:
Baclofen is a prescription medication, and your doctor may order you an additional medication to help manage your pain. The medication should be taken as prescribed by your doctor.
Baclofen is available in several formulations, including:
Baclofen may also be available as an injection (a soft gel or foam) and as a suspension (liquid).
Some healthcare providers will suggest taking Baclofen with food, which can help reduce stomach upset, and/or as directed by a doctor. In some cases, you may take the medication with or without food, and your doctor may suggest taking it with food.
Baclofen may also be used to relieve the following conditions:
Baclofen may be used for the following conditions:
The following may be used for muscle spasms:
Do I need a prescription to take Baclofen?
You should not take more than one medication in any 24-hour period. Baclofen is only available in one dosage or form. If you do need a prescription for one of these medications, talk to your doctor. They will discuss how you may be suitable for the medication and the appropriate dosage for you.
You shoulddonot use Baclofen for more than 3 days unless directed by your doctor. The length of treatment is determined by your doctor, and will depend on your condition and your response to the medication. However, the length of treatment for muscle spasms and stiffness may vary depending on the severity and frequency of your muscle spasms or stiffness. Baclofen may also be used to relieve pain from spasms such as:
If you are unsure whether to take Baclofen, talk to your doctor or pharmacist.
You should not take Baclofen if you have had an allergic reaction to any of the following medications, or any of the ingredients in Baclofen. Symptoms of an allergic reaction may include:
Do not take Baclofen if you are pregnant or breastfeeding. It is not known whether Baclofen is excreted in human breast milk. Baclofen passes into breast milk and may affect the baby. Do not drink alcohol with Baclofen unless your doctor advises you. The medication may affect the way other medicines work and increase your risk of side effects. Before taking the medication, inform your doctor if you have any medical conditions or are taking any other medications. Your doctor will determine if you have a suitable treatment plan for your condition and may increase or decrease the amount of medication you take.
What should I do if I forget to take a Baclofen dose?
If you take a missed dose of Baclofen, take the missed dose as soon as you remember, but do not take a double dose to make up for the missed dose.
Baclofen sales in the USA increased 6 percent to $4.7 billion in the third quarter, a strong sign that a growing number of patients is seeing an increase in their dosage to help relieve muscle pain. The growth in the sales of baclofen, a drug that is used to treat spasticity and muscle pain, is driven by two key factors: increasing incidence and sales of muscle relaxers and increasing demand for muscle relaxants. In the first quarter, the total sales of the generic baclofen market were $3.3 billion, up 9 percent from the first quarter of 2009.
In the first quarter of 2009, the generic baclofen market was dominated by the brand-name drugs Lioresal (baclofen) and Fosamax (amitriptyline). Sales of brand-name baclofen were $4.6 billion, a 4 percent increase from the first quarter of 2009. Sales of the generic drug were $2.4 billion, up 14 percent from the first quarter of 2009. Sales of the brand-name drug Levomax (nortriptyline) were $3.4 billion, up 15 percent from the first quarter of 2009.
In the first quarter of 2009, the total sales of the generic baclofen market were $6.1 billion, up 6 percent from the first quarter of 2009. Sales of the brand-name drug Fosamax (nortriptyline) were $3.6 billion, up 6 percent from the first quarter of 2009. Sales of the brand-name drug Eliquis (venlafaxine) were $3.6 billion, up 6 percent from the first quarter of 2009.
The growth in sales of the generic baclofen market is driven by a number of factors. In the first quarter, the number of patients taking generic versions of baclofen increased by 9 percent to more than 700,000 by the end of 2008, compared to a peak of more than 3,000 patients in the second quarter of 2008. In the first quarter of 2009, the growth in sales of brand-name baclofen was 6 percent to 10 percent, with the growth in total sales of brand-name drugs occurring at 5 percent to 11 percent.
In the first quarter of 2009, the number of patients taking generic versions of baclofen increased by 10 percent to 1,200,000 by the end of 2008, compared to about 1,200,000 by the second quarter of 2009.
Sales of generic baclofen accounted for 6 percent of the sales of the brand-name drug in the first quarter of 2009. The growth in sales of brand-name drugs is driven by the increasing incidence and sales of muscle relaxants, a trend that is driven by the high number of patients being treated with these drugs, particularly because many patients are taking a lower dosage.
Sales of the brand-name drug Levomax (nortriptyline) were up 19 percent from the first quarter of 2009. Sales of the brand-name drug Fosamax (nortriptyline) were up 15 percent from the first quarter of 2009.
Sales of the generic baclofen drug Lyrica (amitriptyline) were up 2 percent from the first quarter of 2009. Sales of the brand-name drug Sustiva (risperidone) were up 6 percent from the first quarter of 2009.
Sales of the brand-name drug Lyrica (risperidone) were up 11 percent from the first quarter of 2009. Sales of the brand-name drug Sustiva (risperidone) were up 10 percent from the first quarter of 2009.
Sales of the brand-name drug Lyrica (risperidone) increased 6 percent to $11.2 billion, up 6 percent from the first quarter of 2009.
The U. S. market for baclofen is driven by a number of factors. In the first quarter of 2009, the number of patients taking generic versions of baclofen increased by 9 percent to more than 700,000 by the end of 2008, compared to about 3,000 patients in the second quarter of 2008.
Sales of the brand-name drug Lioresal (baclofen) decreased by 4 percent to $8.5 billion, up 5 percent from the first quarter of 2009. Sales of the brand-name drug Levomax (nortriptyline) decreased by 4 percent to $2.3 billion, up 7 percent from the first quarter of 2009.
Sales of the brand-name drug Fosamax (nortriptyline) decreased by 4 percent to $3.
A combination of baclofen 10 mg and hydroxyzine 20 mg, a muscle relaxant. Baclofen is effective for the treatment of muscle spasms caused by Parkinson’s disease, post-traumatic stress disorder (PTSD), multiple sclerosis, and other conditions. This medication is taken by mouth. The effects can last for up to eight hours. Baclofen is the generic name for baclofen. It can be used for muscle relaxants. It is used for the treatment of spasticity caused by multiple sclerosis, cerebral palsy, Parkinson's disease, and other neurological disorders. It is also used in the treatment of pain and inflammation. Baclofen should be taken only by mouth. It should not be taken by children, teenagers, or young adults who are taking any form of baclofen. It is not recommended to take baclofen in the elderly. It is also not recommended for children, teenagers, and young adults who are taking any form of baclofen.
Show more in NewsBaclofen 10 mg Tablet is a muscle relaxant used for the treatment of spasticity caused by Parkinson’s disease, post-traumatic stress disorder (PTSD), multiple sclerosis, and other conditions. It is taken by mouth. It can be used for the treatment of muscle relaxants. It is also the generic name for baclofen. It is available in the following strengths: 10 mg, 20 mg, and 40 mg. Each tablet should be swallowed whole with a glass of water. It should not be taken with dairy products. It should not be taken with any other drugs. It is also not recommended to take baclofen with alcohol or tobacco products.
The use of baclofen can cause side effects such as: nausea, vomiting, drowsiness, dizziness, weakness, sweating, blurred vision, and confusion. If any of these effects persist or worsen, stop taking baclofen and seek medical help. Baclofen 10 mg Tablet may cause severe muscle spasms, seizures, and neurological changes, such as: seizures and/or myoclonus. If you have any of these serious side effects, stop taking baclofen and seek medical help.
Baclofen 10 mg Tablet is a muscle relaxant used for the treatment of spasticity caused by Parkinson's disease, post-traumatic stress disorder (PTSD), multiple sclerosis, and other conditions.
The global baclofen market was valued at USD 6.25 billion in 2023[1].
The market is segmented into topical cream, oral suspension, and suspension formulations[1]. The global baclofen market was the third in which of the segments was active disease market. A notable driver for the market is the rising incidence of rheumatic disorders, leading to the demand for baclofen anti-inflammatory drug. This segment is expected to grow as awareness grows regarding rheumatic diseases, with an increased demand for non-steroidal anti-inflammatory drug (NSAID) in the form of oral suspensions. In the market segment, the demand for anti-inflammatory drugs is driven by their ability to decrease inflammation and swelling and relieve pain and inflammation, such as by inhibiting cyclooxygenase (COX) enzymes, which leads to reduced production of prostaglandins. Moreover, oral suspensions are also used as a complementary treatment for pain and inflammation in rheumatic disorders. In addition, the growing awareness about baclofen’s role in managing pain and inflammation is driving the demand for its use in managing pain and inflammation. The rising prevalence of rheumatic disorders, as well as the increasing incidence of inflammatory disorders and acute pain, has led to increased demand for non-steroidal anti-inflammatory drug (NSAIDs) for treating these conditions. The increasing awareness about the management of acute pain, such as rheumatoid arthritis and osteoarthritis, can also contribute to the growing demand for baclofen[1].
The oral suspension market was valued at USD 14.5 billion in 2024 and is projected to grow at a rate of 5.0% from 2024 to 2031[1]. The market is segmented into topical cream, topical suspension, and topical solution forms. The global oral suspension market was the third in which of the segments was active disease market. This segment is expected to grow as awareness about baclofen’s role in managing pain and inflammation is growing. Moreover, the growing demand for its use in managing pain and inflammation, with an increase in patient satisfied with baclofen treatment, can also drive the demand for its use in treating pain and inflammation.
The opioid epidemic, which has affected approximately 15 million American adults, has led to the use of baclofen as an opioid pain medication, leading to a rise in the use of opioids like hydric oxide and oxycodone as an addiction treatment. The demand for baclofen as an opioid analgesic has also increased due to the sale of generic opioids like morphine and oxycodone as an addiction treatment. In addition, the growing demand for opioid medications in the healthcare system can also drive the demand for baclofen[1].
The increasing prevalence of psychiatric disorders, such as in the form of mood disorders or disorders characterized by deep sadness and inattention, can also drive the demand for non-opioid analgesics like baclofen. The growing use of psychiatric drugs, such as medication as a treatment for depression and other mental health conditions, can also drive the demand for baclofen[1].
The rising incidence of rheumatic disorders, leading to the growing demand for topical cream, oral suspension, and solution forms of baclofen are both significant growth drivers for the market. The increasing demand for NSAIDs, such as baclofen, along with the growing number of people suffering from acute pain, can also drive the demand for its use in managing pain and inflammation. The increasing availability of generic opioids like morphine and oxycodone as treatment for depression and other mental health conditions, can also drive the demand for its use in managing pain and inflammation. The growing awareness about management of acute pain and the increasing prevalence of psychiatric disorders, coupled with the growing use of psychiatric medications in treating pain and inflammation, can also help drive the demand for baclofen[1].
The global baclofen market is segmented into topical cream, topical suspension, and solution forms. The global topical cream market was the third in which of the markets was active disease market. A notable driver for the segment is the rising incidence of rheumatic disorders, leading to the growing demand for baclofen. This segment is expected to grow as awareness about management of acute pain, such as in the form of topical cream, oral suspension, and solution forms of baclofen is increasing.
The global topical cream market was the largest in which of the markets was active disease market.
Stade de France Pharmacy